BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/25/2025 6:55:46 AM | Browse: 13 | Download: 0
Category |
Medicine, Research & Experimental |
Manuscript Type |
Retrospective Cohort Study |
Article Title |
Efficacy of adjuvant chemotherapy in stage II colon cancer patients with twelve or more lymph nodes retrieve
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Yu Huo, Yue-Yang Zhang, Shuai Jiao, Zhong-Yuan Bai, Wen-Qi Bai, Hai-Tao Zhou and Xu Guan |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Shanxi Special Projects of the Central Government Guiding Local Science and Technology Development of China |
YDZJSX2021B016 |
Shanxi Cancer Hospital Doctoral Master's Guide and Companion Flying Fund |
SD2023010 |
|
Corresponding Author |
Wen-Qi Bai, Department of General Surgery Sciences, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, No. 3 Xinghualing District Workers’ New Village, Taiyuan 030000, Shanxi Province, China. baiwenqi1998@163.com |
Key Words |
Stage II; Colon cancer; Lymph nodes; Chemotherapy; Prognosis |
Core Tip |
No adjuvant chemotherapy (ACT) continues to be a significant independent predictor for patients with stage II colon cancer who have 12 or more lymph nodes (LNs) removed. Even among these patients with T3 stage and grade 1/2, ACT still leads to improved prognosis. Based on two large-scale population-based cohorts and the propensity score matching method, we validated the generalizability and reliability of these findings. This research confirms that patients with adequate LNs retrieval (≥ 12 LNs) can still benefit from ACT, which is expected to provide valuable insights and further guide clinical practice in the management of colorectal carcinoma. |
Citation |
Huo Y, Zhang YY, Jiao S, Bai ZY, Bai WQ, Zhou HT, Guan X. Efficacy of adjuvant chemotherapy in stage II colon cancer patients with twelve or more lymph nodes retrieve. World J Gastrointest Oncol 2025; In press |
 |
Received |
|
2025-04-15 11:12 |
 |
Peer-Review Started |
|
2025-04-15 11:12 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-05-15 12:00 |
 |
Revised |
|
2025-05-26 10:31 |
 |
Second Decision |
|
2025-07-25 02:40 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-07-25 06:55 |
 |
Articles in Press |
|
2025-07-25 06:55 |
 |
Publication Fee Transferred |
|
2025-05-28 10:33 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345